Ritter stock: buy or sell?

RTTR stock price: $0.28 33.33% At close on February 27th, 2020

Updated on:
February 27th, 2020

1

Ritter Pharmaceuticals shares broke up the simple moving average line of 100 days today and closed at $0.28, skyrocketed a 33.33%.

Ritter Pharmaceuticals, Inc., a specialty pharmaceutical company, develops novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases.

Should I buy Ritter stock?

Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.

None of our preferred buy setups matches with Ritter stock situation right now, therefore this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean RTTR will fall in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is Ritter Pharmaceuticals stock a buy?

Financial institutions and banks post stock ratings everyday. Unfortunately, we couldn't find any rating for RTTR stock for the last 30 days.

Ritter stock analysis

Daily outlook

Ritter Pharmaceuticals shares crossed up the simple moving average line of 100d today and closed at $0.28, skyrocketed a 33.33%.

Ritter Pharmaceuticals crossed up the simple moving average line of 100d today and closed at $0.28.

RTTR stock chart (daily)

Weekly outlook

Ritter rocketed an extraordinary 21.74% this week. By mid February RTTR plunged a scary -10.53% in just one week.

Ritter Pharmaceuticals stock is drawing an uptrend with rising tops and bottoms. Now trading in between its last bottom and last top, RTTR might consolidate in a flat-base, waiting to break out over or down under . Since early September 2019, when RTTR stock price broke down the 40-weeks moving avarage line, it slid $-0.88 per share (-75.86%). Stocks under the 200 days moving average line are usually not recommended for average traders.

RTTR stock chart (weekly)

Ritter stock price history

Ritter IPO was on June 24th, 2015 at $50.00 per share1. Since then, RTTR stock sliced a -99.40%, with a yearly average of -24.90%.

1: Adjusted price after possible price splits or reverse-splits.

Ritter stock historical price chart

RTTR stock reached 52-week highs on March at $1.35, and all-time highs 2015-06-24 with a price of 55.

Ritter stock price target

Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' RTTR stock price predictions in the hope that they will be met as they may be wrong and not met. For the last month we have not detected any price target for Ritter Pharmaceuticals stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

Since March, when Ritter published its last earnings report, it . As soon as we get its actual EPS from the earnings report, we will extend this review.
RTTR earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q1-n/a-0.14n/a
2017-Q2-n/a-0.14n/a
2017-Q3-n/a-0.14n/a
2017-Q42018-03-19-0.5-1.1n/a
2018-Q12018-05-15-0.4-0.41n/a
2018-Q22018-08-14-0.63-0.71n/a
2018-Q32018-11-09-0.84-0.83n/a
2018-Q42019-03-29n/a-1.66n/a
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a

Annual financial results

In , Ritter annual turnover to million dollars from marked in . When comparing vs , , profit margin (that is, the net income divided by revenues) a to .

RTTR annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY

Quarterly financial results

Reported quarter income marked $-6.63 million with a profit margin of . Profit margin stayed constant a 0.00% compared to previous quarter when profit margin was inf%. When comparing revenues to same quarter last year, Ritter sales marked a tight movement and remained steady a nan%. Looking back to recent quarterly results, Ritter Pharmaceuticals posted 7 positive quarters in a row.
RTTR quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2

Ritter ownership

When you are planning to buy a stock, it's worth to overview its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Ritter Pharmaceuticals, 9.42% of all outstanding shares are owned by its staff.

In case of Ritter stock, 7.78% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for RTTR stock account 0.00%, no big difference from last month.

For a better understanding, the next table shows ownership data compared to other related stocks:

RTTR
Market cap$9.1 M
Total shares32.7 M
Float shares8.6 M
  - Institutional holdings (%)7.8%
  - Insider holdings (%)9.4%
Shares in short selling0.0%

Ritter summary

Thursday, February 27th, 2020
Open$0.21
Close$0.28
Day range$0.21 - $0.37
Previous close$0.21
Session gain33.33%
Average true range$0.03
50d mov avg$0.20
100d mov avg$0.22
200d mov avg$0.54
Daily pattern
Weekly pattern lt06a

Ritter performance

Stocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. In the following table, we compare Ritter performance to :
Stock3m6m12m
RTTRRitter Pharmaceut...55.56%-72.82%-56.25%

Ritter competitors

Unfortunately, we could not find any public company that could be defined as Ritter Pharmaceuticals competitor. This doesn't mean Ritter Pharmaceuticals does not have any competitor in the market, it's just we could not detected it.